Xiaocen Kong

749 total citations
32 papers, 582 citations indexed

About

Xiaocen Kong is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Physiology. According to data from OpenAlex, Xiaocen Kong has authored 32 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Epidemiology and 10 papers in Physiology. Recurrent topics in Xiaocen Kong's work include Adipose Tissue and Metabolism (6 papers), Diabetes Management and Research (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Xiaocen Kong is often cited by papers focused on Adipose Tissue and Metabolism (6 papers), Diabetes Management and Research (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Xiaocen Kong collaborates with scholars based in China, Singapore and Australia. Xiaocen Kong's co-authors include Jianhua Ma, Jing Yu, Shan Lv, Xiaofei Su, Wenjuan Di, Huiqin Li, Hanmei Qi, Hong Zhou, Juan Liu and Yunlu Sheng and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Diabetes.

In The Last Decade

Xiaocen Kong

31 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaocen Kong China 17 238 178 165 128 100 32 582
Xiaoyang Lai China 13 289 1.2× 84 0.5× 89 0.5× 127 1.0× 84 0.8× 27 551
Sergio Chiandotto Italy 7 398 1.7× 208 1.2× 103 0.6× 74 0.6× 53 0.5× 12 705
Sandhya S. Thomas United States 13 316 1.3× 174 1.0× 78 0.5× 56 0.4× 55 0.6× 20 591
Yongzheng Guo China 16 273 1.1× 156 0.9× 83 0.5× 70 0.5× 50 0.5× 34 559
Yachen Shen China 10 177 0.7× 237 1.3× 63 0.4× 166 1.3× 43 0.4× 15 516
Norito Yagihashi Japan 14 246 1.0× 154 0.9× 136 0.8× 111 0.9× 43 0.4× 21 678
Byung‐Hyun Park South Korea 14 206 0.9× 99 0.6× 70 0.4× 101 0.8× 38 0.4× 15 531
Leiluo Geng Hong Kong 8 502 2.1× 268 1.5× 84 0.5× 247 1.9× 50 0.5× 13 888
Yanmei Zeng China 12 199 0.8× 74 0.4× 143 0.9× 67 0.5× 45 0.5× 22 422
Seok‐Woo Hong South Korea 13 225 0.9× 84 0.5× 187 1.1× 166 1.3× 41 0.4× 22 526

Countries citing papers authored by Xiaocen Kong

Since Specialization
Citations

This map shows the geographic impact of Xiaocen Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaocen Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaocen Kong more than expected).

Fields of papers citing papers by Xiaocen Kong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaocen Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaocen Kong. The network helps show where Xiaocen Kong may publish in the future.

Co-authorship network of co-authors of Xiaocen Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaocen Kong. A scholar is included among the top collaborators of Xiaocen Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaocen Kong. Xiaocen Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Li, Min, Shunyou Gong, Xiulian Miao, et al.. (2025). Interferon regulatory factor 1 contributes to metabolic dysfunction associated steatotic liver disease. Life Sciences. 370. 123575–123575. 1 indexed citations
3.
Kong, Xiaocen, et al.. (2025). Effect of Ebenatide on glycemic metabolism and body fat in patients with type 2 diabetes mellitus. Frontiers in Endocrinology. 16. 1622526–1622526.
5.
Yin, Xia, Jing Jin, Yaqin Sun, et al.. (2024). Tirzepatide’s role in targeting adipose tissue macrophages to reduce obesity-related inflammation and improve insulin resistance. International Immunopharmacology. 143(Pt 2). 113499–113499. 18 indexed citations
6.
Liu, Bingli, Liping Su, Sze Jie Loo, et al.. (2024). Matrix metallopeptidase 9 contributes to the beginning of plaque and is a potential biomarker for the early identification of atherosclerosis in asymptomatic patients with diabetes. Frontiers in Endocrinology. 15. 1369369–1369369. 7 indexed citations
7.
Ma, Jingjing, Yuanyuan Liu, Xia Yin, et al.. (2024). Tirzepatide administration improves cognitive impairment in HFD mice by regulating the SIRT3-NLRP3 axis. Endocrine. 87(2). 486–497. 5 indexed citations
8.
Xia, Yin, Xiaocen Kong, Yunting Zhou, et al.. (2024). Association Between Serum Zinc and Non-Alcoholic Fatty Liver Disease and Advanced Liver Fibrosis: NHANES 2011–2016. Biological Trace Element Research. 203(3). 1305–1316. 6 indexed citations
9.
Su, Liping, Xiaocen Kong, Yu Gao, et al.. (2022). Thymosin beta-4 improves endothelial function and reparative potency of diabetic endothelial cells differentiated from patient induced pluripotent stem cells. Stem Cell Research & Therapy. 13(1). 13–13. 14 indexed citations
10.
Kong, Xiaocen, et al.. (2019). Association between Free Thyroxine Levels and Diabetic Retinopathy in Euthyroid Patients with Type 2 Diabetes Mellitus. Endocrine Research. 45(2). 111–118. 18 indexed citations
11.
Yu, Jing, Yifan Lv, Fengliang Wang, et al.. (2019). MiR-27b-3p Inhibition Enhances Browning of Epididymal Fat in High-Fat Diet Induced Obese Mice. Frontiers in Endocrinology. 10. 38–38. 23 indexed citations
13.
Lv, Yifan, Jing Yu, Yunlu Sheng, et al.. (2017). Glucocorticoids Suppress the Browning of Adipose Tissue via miR-19b in Male Mice. Endocrinology. 159(1). 310–322. 27 indexed citations
14.
Zeng, Sheng, Yuyu Yang, Xian Cheng, et al.. (2016). HIC1 epigenetically represses CIITA transcription in B lymphocytes. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1859(12). 1481–1489. 8 indexed citations
15.
Fan, Zhiwen, Xiaocen Kong, Jun Xia, et al.. (2016). The arginine methyltransferase PRMT5 regulates CIITA-dependent MHC II transcription. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1859(5). 687–696. 19 indexed citations
16.
Wu, Lin, Hanmei Qi, Yi Zhong, et al.. (2013). 11β-hydroxysteroid dehydrogenase type 1 selective inhibitor BVT.2733 protects osteoblasts against endogenous glucocorticoid induced dysfunction. Endocrine Journal. 60(9). 1047–1058. 15 indexed citations
17.
Wang, Long, Juan Liu, Aisen Zhang, et al.. (2012). BVT.2733, a Selective 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor, Attenuates Obesity and Inflammation in Diet-Induced Obese Mice. PLoS ONE. 7(7). e40056–e40056. 33 indexed citations
18.
Wu, Xiaoyan, Xiaocen Kong, Dewei Chen, et al.. (2011). SIRT1 links CIITA deacetylation to MHC II activation. Nucleic Acids Research. 39(22). 9549–9558. 30 indexed citations
19.
Fang, Mingming, Xiaocen Kong, Ping Li, et al.. (2009). RFXB and its splice variant RFXBSV mediate the antagonism between IFNγ and TGFβ on COL1A2 transcription in vascular smooth muscle cells. Nucleic Acids Research. 37(13). 4393–4406. 29 indexed citations
20.
Kong, Xiaocen, Mingming Fang, Fei Fang, Ping Li, & Yong Xu. (2009). PPARγ enhances IFNγ-mediated transcription and rescues the TGFβ antagonism by stimulating CIITA in vascular smooth muscle cells. Journal of Molecular and Cellular Cardiology. 46(5). 748–757. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026